Background: Grey matter and other structural brain abnormalities are consistently reported in first-onset schizophrenia, but less is known about the extent of neuroanatomical changes in firstonset affective psychosis.
INTRODUCTION
Neuroimaging studies of first-episode schizophrenia have shown neuroanatomical abnormalities, including ventricular enlargement (Cahn et al, 2002) and subtle grey matter deficits in the whole brain (Fannon et al, 2000a) , frontal and temporal lobes (Job et al, 2002) . Furthermore, some abnormalities such as basal ganglia enlargement seem to appear early in the illness but only following antipsychotic exposure (Lawrie et al, 1998) . While abnormalities in the cingulate gyrus (Sassi et al, 2004) and temporal lobe (Kasai et al, 2003a) have been observed in first-onset affective psychosis, it is not clear whether they are as frequent and severe as in schizophrenia.
Using high resolution MRI and voxel-based morphometry (VBM) methods of image analysis, we set out to examine the brain structure of patients participating in an epidemiological study of first-episode psychosis. We predicted that compared to healthy controls, patients with schizophrenia and affective psychosis would have frontal and temporal lobe grey matter deficits and increased ventricular and striatal volumes, but that those abnormalities would be more severe in schizophrenia.
SCAN data, we encoded (in weeks): duration of illness (DOI) as the onset date of psychotic symptoms to MRI date; and lifetime duration of antipsychotic exposure (DAE) (to MRI date).
Total symptomology was scored by summing the WHO-SCAN's individual item scores using the algorithm of Wing and Sturt (1978) .
Structural MR Image acquisition
Scans were acquired with a GE Signa 1.5-T system, at the Maudsley Hospital, London.
Contiguous, interleaved proton-density-and T2-weighted 3mm thick coronal plane dual-echo images were acquired, providing whole brain coverage. A repetition time of 4000ms and effective echo times of 20ms and 85ms were used with 8-echo train length. Matrix size was 256
x 192, collected from a rectangular field-of-view of 22cm x 16.5cm, giving an in-plane resolution of 0.859mm. Total acquisition time was 10 minutes, 12 seconds.
Structural MR Image processing
The methods used for segmentation and registration of each fast spin echo dataset are described in detail elsewhere (Bullmore et al, 1999 , Suckling et al, 1996 . Briefly, subject masks were generated to identify neural tissue. Extra-cerebral tissues were removed initially, using an automated algorithm. Manually editing the skull-stripped images was necessary only to remove brainstem and cerebellum from the cerebral hemispheres and diencephalon. The probability of each intracerebral voxel belonging to each of four possible tissue classes (grey matter, white matter, cerebro spinal fluid [CSF] , or dura/vasculature) was estimated with a modified fuzzy clustering algorithm (Suckling et al, 1996) . This type of segmentation assigns for each voxel, a value in the range 0-1 indicating the fraction of the voxel comprised by each tissue type (e.g. a grey matter value of 0.7, means 70% of tissue represented by that voxel is grey matter; therefore the value indicates the proportion of the voxel occupied by grey matter). Total grey tissue volume was calculated at this stage of the analysis.
The construction of the sample's template image is described elsewhere (Dazzan et al, 2004) . In summary, a template image was constructed using the AFNI (Analysis of Functional Neuroimages) program from 6 proton-density images acquired from 6 healthy controls and then averaging these images. Tissue distribution maps were registered onto the template by first registering each subject's proton density image using a 9-parameter affine registration, minimising between image grey-level difference between images. This registration aligns all the images together, and scales them to the same gross dimensions. The derived mapping was then applied to the corresponding tissue maps.
Ventricular volume
Additional masks were generated per subject by tracing around the lateral and third ventricles in native space, in every slice in which they were visible. Ventricles were traced by one rater (SJP), blind to age, sex, ethnicity and patient/control status. Within the masked area, CSF volume was calculated using the data generated from the previously described modified fuzzy clustering algorithm.
Statistical Analysis
Between-group regional differences in grey matter volume were estimated by fitting an analysis of covariance (ANCOVA) model at each intracerebral voxel in standard space covarying for age and total grey matter volume. Permutation testing was used to assess statistical significance, and regional relationships were tested at voxel cluster level (Bullmore et al, 1999 , Sigmundsson et al, 2001 . Given that structural brain changes are likely to extend over a number of contiguous voxels, test statistics incorporating spatial information, such as 3D cluster mass (the sum of suprathreshold voxel statistics), are generally more powerful than other possible test statistics informed only by single voxel data. We set the statistical threshold for cluster significance in all analyses so that the expected number of false positive clusters (p-value times number of tests) was <1 false positive. We examined the association between grey matter cluster size with measures for DOI, DAE and total symptoms using Pearson correlation coefficients. Students T test calculations were used to analyse between-group differences in ventricle to brain volume ratio (VBR) and total grey matter and CSF volume. 1   TABLE 2 44 patients received an ICD-10 schizophrenia diagnosis and 29 patients a diagnosis of bipolar disorder (n=17) or psychotic depression (n=12). T-tests and Chi Square analyses showed there were no significant differences between the 'Schizophrenia' and 'Affective Psychosis' groups in terms of DOI, DAE, total symptom scores and number of compulsory admissions. The percentage of patients who were prescribed atypical antipsychotics was higher among patients with schizophrenia than in those with affective psychosis (22 [50%] versus 2 [7%], χ2= 16.7, p<.001). More patients with affective psychosis were prescribed typical antipsychotics (48%) than patients with schizophrenia (30%). This difference did not reach statistical significance.
RESULTS

TABLE
( Table 2 ).
Schizophrenia versus controls
Patients with schizophrenia had, on average, 2 less years of education (mean 12.4 
001). T-tests and Chi Square
analyses showed there were no significant differences between the schizophrenia patients and controls in terms of age, gender, handedness, parental socio-economic status (PSES) and ethnicity. (Table 1) .
Total tissue and ventricular volumes
There were no between-group differences in total grey matter or CSF volume. However, patients with schizophrenia had significantly larger lateral ventricle VBR (+24.9% volume: t=2.33, df=86, p<.03) and larger third ventricle VBR (+63.2% volume: t=3.08, df=86, p<.01) than healthy controls. (Table 3) .
Regional proportional grey tissue volume differences
There were no regional differences in grey matter volume between patients and controls. (Table   4 ).
However, a secondary analysis of the grey matter map using a lowered statistical threshold for cluster significance (p-value set at .01), detected 3 excess grey matter areas and 1 grey matter deficit area in the patients. The excess clusters were located in the left and right lenticular nucleus and the right precentral gyrus. The deficit cluster was located at the right parahippocampal gyrus.
Symptomology, DOI and DAI
These clinical factors were not associated with lateral or third ventricle volume (Table 4) .
Affective psychosis versus controls
T-tests and Chi Square analyses showed there were no significant differences between the affective patients and controls in terms of age, gender, years of education, NART, handedness, PSES and ethnicity. (Table 1) .
Total tissue and ventricular volumes
There were no between-group differences in total grey matter or CSF volume. Patients with affective psychosis had larger third ventricle VBR than controls (+70% volume: t=2.72, df=56, p<.01), but there was no significant between-group difference in lateral ventricle volume. (Table 3) .
Regional proportional tissue volume differences
Four regional clusters of grey matter deficit were identified in patients with affective psyhcosis compared to the controls. These were located: 1) bilaterally within the anterior cingulate gyrus (centred Brodmann's Area (BA) 24), and extending anteriorly to BA31 and BA31 and posteriorly to BA23; 2) within the left insula; 3) at the right postcentral gyrus (BA1 and BA2); 4) at the left fusiform gyrus (BA37) and extending laterally into the lingual gyrus. The patients had a single grey matter excess cluster located in the left lenticular nucleus. (Table 4 ; Figure 1 ).
Symptomology, DOI and DAE
Longer DAE correlated with increased third ventricle volume (r=.49, p=.007) and increased lateral ventricle volume (r=.54, p=.003). Increased third ventricle volume correlated with higher total symptom scores (r=.41, p=.03). The amount of grey matter in the regional deficit and excess tissue clusters identified did not correlate with symptomology scores, DOI or DAE. (Table 4) . p=.079). T-tests and Chi Square analyses showed there were no significant differences between the two patient groups in terms of handedness, parental socio-economic status (PSES) and ethnicity. (Table 1) .
Total tissue and ventricular volumes
An ANCOVA (controlling for age and sex) was used compare total tissue and ventricular volumes. There were no between-group differences in total grey matter, CSF volume or ventricular volumes. (Table 3) .
Regional proportional grey tissue volume differences
In addition to age and total grey matter volume, sex was also added as a covariate in the analysis of regional grey matter differences. One regional cluster of grey matter deficit was identified in the affective psychosis group. This was located bilaterally within the anterior cingulate gyrus, centred on Brodmann's Area (BA) 24, and extending anteriorly to BA31 and BA32 and posteriorly to BA23. (Table 4) . As there were significant differences in the type of antipsychotic taken, an additional analysis adding type of antipsychotic as a covariate (typicals, atypicals or none) was performed. When type of antipsychotic was added as a covariate, there were no differences between groups in regional grey matter.
DISCUSSION
In contrast with other first-onset MRI investigations, we found relatively few structural abnormalities in schizophrenia but identified several regional grey matter deficits in the affective psychoses. Furthermore, in patients with affective disorders, but not with schizophrenia, we found increased ventricular volumes to be associated with higher total symptom ratings and longer lifetime use of antipsychotics.
Schizophrenia
Our finding of increased ventricular volume is consistent with other first-episode schizophrenia studies (Fannon et al, 2000b , Cahn et al, 2002 . Evidence of ventricular enlargement in firstepisode patients either never treated, or minimally treated with antipsychotics (Fannon et al, 2000b) suggests that this abnormality either predates or closely follows psychosis onset and it is perhaps of note that in our sample, ventricular abnormalities in schizophrenia were not associated with symptomology, DOI or DAE. Contrary to our prediction that patients with schizophrenia would show frontal and temporal grey matter reductions and increased striatal grey matter, no grey matter abnormalities were found. To explore the possibility that this could have been due to a lack of statistical power, we re-ran the grey matter comparison using a lower statistical threshold. This analysis identified grey matter differences in two of the predicted locations: lenticular nuclei increases (left and right) and reductions in the right parahippocampal gyrus (part of the temporal lobe). Although in this post-hoc analysis the possibility of falsepositive Type 1 errors is increased, the findings may nevertheless indicate the presence of a pattern of structural abnormalities similar but less pronounced than that reported elsewhere (Fannon et al, 2000a , Job et al, 2002 , Lawrie et al, 1998 .
Affective Psychosis
We found enlargement of third ventricle in the affective psychoses, but in contrast to the schizophrenia patients, this was correlated with higher total symptom scores and longer DAE.
The latter may indicate that this brain abnormality is less likely to reflect neurodevelopmental pathology than in schizophrenia
The grey matter deficits we found are in line with other studies of affective disorders. Anterior cingulate gyrus (ACG) deficits have been found in bipolar disorder (Sassi et al, 2004 ) and major depression (Bremner et al, 2002) and in people with a genetic risk for bipolar disorder, but not for schizophrenia (McDonald et al, 2004) . Findings such as these suggest a role for the ACG in the regulation of emotions. Combined ratings for affective symptoms (depression and mania) in the affective psychosis group were as one might expect higher than in the schizophrenia group (t=2.8, p=.008), but a post-hoc analysis showed no correlation between severity of affective symptoms and the amount of grey matter in the ACG cluster.
Recent findings have shown left fusiform grey matter deficits in patients with mixed psychotic disorders, scanned one year after psychosis onset (Pantelis et al, 2003) . The possible role of the fusiform gyrus in the psychopathology of psychosis remains unclear but it has been suggested that it is implicated in the appraisal and encoding of faces in disorders such as schizophrenia (Onitsuka et al, 2003) . In our sample we found no correlation between fusiform grey matter volume and symptoms scores, DOI and DAE. Similarly, no association was found between those variables and grey matter volume in the two other deficit regions identified in our affective psychotic patients: the post central gyrus and the left insula. While a recent VBM study (Job et al, 2002) observed reduced postcentral gyrus grey matter in schizophrenia, there have been few reports elsewhere in the psychosis literature of structural abnormalities in this region. On the other hand, left insula grey matter deficits have previously been reported in VBM studies of affective psychosis (Kubicki et al, 2002) , as well as in first-onset schizophrenia (Kasai et al, 2003b ) and schizophrenia of mixed chronicity (Kubicki et al, 2002) .
The finding of more grey matter deficits in affective psychosis than in schizophrenia was contrary to our predictions and is at variance with other studies of psychosis. It is unlikely the findings can be accounted for by anomalies in image acquisition or processing as such effects
would not occur systematically in one group only. One possible confounder is between-patient group differences in prescribed antipsychotics; this could provide some explanation for these findings as recent research suggests different effects of typical and atypical antipsychotics on brain structure (Lieberman et al, 2005; Garver et al, 2005) . Indeed, in an earlier analysis of our sample (Dazzan et al, 2005) we found that, in comparison to drug-free patients, patients taking typicals, but not those taking atypicals had smaller volumes in the lobulus paracentralis; anterior cingulate gyrus; superior and medial frontal gyri; superior and middle temporal gyri; insula; and precuneus. It is conceivable that such an effect might explain the greater deficits in the affective psychosis group rather than the schizophrenia group as more patients with affective psychosis were taking typical antipsychotics (48%) than patients with schizophrenia (30%) and significantly more patients with schizophrenia were taking atypicals (50% versus 7%). A role for differences in pharmacological treatment was confirmed by our additional analysis showing that when these differences are taken into account, there are no regional differences in brain structure between patient groups.
Treatment with typical antipsychotics may also be relevant to the increased left lenticular nucleus grey matter as these drugs have a strong affinity to sub-cortical D2 dopamine receptors and receptor blockade may induce cellular growth and increase blood-flow (Corson et al, 2002) .
Striatal enlargement appears less likely in patients treated only with atypical antipsychotics (Corson et al, 1999) , which have weaker D2 receptor affinity. Indeed, in a previous analysis on this first-onset sample, we showed that patients treated with atypicals have similar striatal volumes to drug-free patients, while subjects taking typicals had significantly larger basal ganglia volumes than drug-free patients (Dazzan et al, 2005) .
Schizophrenia and affective psychosis
A direct comparison of the two patients groups (controlling for between-group differences in age, sex and total grey matter volume) revealed grey matter of the anterior cingulate gyrus in the affective psychosis patients, but no other neuroanatomical differences. This was consistent with the findings of the patient-control comparisons. The affective psychosis patients were prescribed more typical antipsychotics and significantly less atypical antipsychotics than the patients with schizophrenia. When the analysis was repeated controlling for type of antipsychotic, no between group differences were found. This suggests that grey matter changes may be associated with variations in the type antipsychotic taken and is consistent with our previous finding of typicals being associated with grey matter reductions in the anterior cingulate gyrus (Dazzan et al, 2005) .
The finding of regional deficits in the patients with affective psychosis was of interest and indicates that some morphological changes take place in those patients close to illness onset or at prodromal or even premorbid stage. We found significant, but fewer neuroanatomical abnormalities in schizophrenia. The absence of more widespread differences in these patients might be accounted for by the epidemiological basis of our study, in which both patients and controls were recruited from the same catchment area. Using an epidemiologically based sample avoids the potential bias of recruiting subjects according to factors such as illness severity and family history. Many reports on first-episode schizophrenia patients come from university clinics, referral centres and in-patient samples which attract subjects not necessarily representative of first-episode schizophrenia in general (Job et al, 2002 , Pantelis et al, 2003 and it is possible that our findings do not reflect the findings reported in patients with more severe illnesses. The use of an epidemiological sample may also explain in part, the findings in the affective psychosis sample. The recruitment of those patients was not based on referrals from bipolar and other affective clinics and may have resulted in a more psychotic affective sample than that seen in earlier MRI studies of affective disorders.
CLINICAL IMPLICATIONS
• Ventricular enlargement was associated with symptomology and duration of illness in affective psychosis but not in schizophrenia. This may indicate that this particular brain abnormality is more likely to reflect a neurodevelopmental pathology in schizophrenia compared to the affective psychoses.
• As in schizophrenia, patients with affective psychotic disorders show subtle neuroanatomical changes early in their illness,
• Differential treatment with typical and atypical antipsychotics may contribute to brain structural differences seen in patients with schizophrenia and affective psychosis.
LIMITATIONS
• The finding of grey matter abnormalities in the schizophrenia patients at a lower statistical threshold suggests that more grey matter changes in this group may have been identified in a larger sample.
• Because there may be longitudinal MRI changes following the first episode, a different pattern of group differences may be evident when patients are studied later in the illness.
• Our appraisal of the relationship between antipsychotic medication, grey matter change and diagnosis was limited by the fact that patients could not be selected into the study of their basis of drug prescription (or drug free) status. 
